Transforming Parkinson Detection
Exploring new biological definitions and their impact on Parkinson's disease early diagnosis and treatment.
Topline
The integration of alpha-synuclein biomarkers into Parkinson's disease diagnosis could revolutionize early detection and treatment strategies, potentially leading to more accurate and timely interventions.
Study Details
Parkinson's disease (PD) and dementia with Lewy bodies have traditionally been diagnosed based on clinical symptoms, which often v…
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.